Isomorphic Labs secures $5 billion to accelerate AI in medicine, Demis Hassabis states

Isomorphic Labs secures $5 billion to accelerate AI in medicine, Demis Hassabis states
Isomorphic Labs $5 billion AI drug funding

Isomorphic Labs has announced $5 billion in funding aimed at accelerating its efforts to transform drug design using artificial intelligence.

Demis Hassabis said the new capital will support the company’s mission to radically reduce the time and cost required to discover new medicines by reimagining drug design from first principles with AI.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.